Creating Partnerships that Make a Difference
At AbbVie, we partner to achieve two important outcomes: deliver innovative medicines and make a remarkable impact on people’s lives.
We start with a highly integrated approach to developing and sustaining our partnerships. We work as one connected unit with a commitment to establishing collaborations across the development continuum that will ultimately benefit patients and fuel scientific progress.
Whether partnering with a business, academia or consortia, our goal is to create long-term mutually beneficial relationships. For example, for a smaller biotech partner, AbbVie’s global medical affairs and commercial reach may enable their product to benefit patients worldwide. Large pharmaceutical partnerships allow each company to contribute the strengths of their organization.
With a shared vision as our foundation, we align our capabilities to conduct groundbreaking science and bring innovative medicines to societies around the globe. From start to finish, we manage our partnerships for success—from early identification and mitigation of risks to shared accountability and reward for successful outcomes. Our partners and our strong team help make this possible.
How We Work Together
Business Development and Acquisitions
Our business development team evaluates a variety of partnership structures to meet the needs of both parties. They work closely with our commercial and R&D organizations to evaluate new opportunities that complement and enhance our existing internal innovation strategy.
Highly successful partnerships result from an ongoing commitment to realize a shared vision. At AbbVie, we have a dedicated team that is involved in all aspects of the partnership from contracting through commercialization to ensure positive outcomes for all parties.
We strategically invest in transformational scientific opportunities to augment our core R&D interests and gain access to next-generation science and proven scientific leaders. Our expertise in drug development and commercialization can be a valuable resource to even the earliest stage companies.